Meril, an Indian company, has launched the Mizzo Endo 4000, an advanced robotic surgical system that uses AI and 5G to enable ...

IND clearance marks second study accepted for RLS-1496, a first-in-class disease-modifying selective GPX4 modulator targeting pathological senescent cells that drive inflammaging and chronic ...

Back to School Without the Math Meltdowns Back to school should feel like popping champagne—not hiding in the pantry with a ...

PALI-2108 demonstrated favorable safety, with no serious adverse events, lab abnormalities, or EKG concerns Phase 1b data demonstrated 100% clinical response and promising signals regarding the ...

An artificial neuron made of conductive plastics that can perform advanced functions similar to those of biological nerve cells has been demonstrated ...

UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).

The starchy root vegetable, cassava, is extremely important to more than a billion people worldwide, mainly across the ...

Vir Biotechnology, Inc. ( NASDAQ: VIR) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:05 PM EDT ...

Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical necessity.

编者按：近年来，寡核苷酸类药物凭借其直接调控基因表达的独特机制，在中枢神经系统（CNS）疾病治疗领域展现出巨大潜力，受到业内广泛关注。迄今为止，美国FDA已批准多款寡核苷酸药物用于CNS疾病的治疗，如脊髓性肌萎缩症（SMA）和肌萎缩侧索硬化症（ALS ...

Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)Planning ...